Breast Cancer
Research Study
Researchers at The University of Alabama at Birmingham are examining the effects of exercise on the gut microbiome of breast cancer survivors. Join our compensated study today!
Fast Facts
18-74 years old
History of Breast cancer
at least one year post completion of breast cancer treatment
Compensation Provided
conducted in Birmingham, AL
Study Background
Researchers at The University of Alabama at Birmingham are conducting a research study to evaluate how breast cancer survivors’ gut microbiome is affected by regular exercise.
This investigation is known as the ROME Study, which is The Role of Gut Microbe Composition in Psychosocial Symptom Response to Exercise Training in Breast Cancer Survivors.
Findings from this clinical research study will provide information on the relationship between cardiorespiratory fitness and gut microbiota in women with a history of breast cancer.
Participants will complete a 10-week exercise training intervention, provide specimens, and undergo physical assessments.
Further research today and join our compensated study!
Study Background
Researchers at The University of Alabama at Birmingham are conducting a research study to evaluate how breast cancer survivors’ gut microbiome composition is affected by regular exercise.
This investigation is known as the ROME Study, which is The Role of Gut Microbe Composition in Psychosocial Symptom Response to Exercise Training in Breast Cancer Survivors.
Findings from this clinical research study will provide information on the relationship between cardiorespiratory fitness and gut microbiota composition in women with a history of breast cancer.
Participants will complete a 10-week aerobic exercise training intervention, provide specimens, and undergo medical evaluations.
Further research today and join our compensated study!
Additional Information
You may qualify for this research study if you meet the following criteria.
Key Criteria:
- Women ages 18 to 74
- History of ductal carcinoma in situ (DCIS) or breast cancer stage 0, I, II, III
- At least one year post completion of primary treatment for breast cancer (chemotherapy and/or radiation)
- Physician medical clearance for study participation
- Able to ambulate without assistance
- No antibiotics for the past 90 days
- Willing to avoid taking probiotics for the duration of the study
Once enrolled, this study involves:
- Participating in a 10-week exercise training intervention
- Following a standardized dietary intake
- Completing physical assessments and specimen collections
